Camlin Fine Sciences Limited

BSE: 532834 NSE: CAMLINFINE
Camlin Fine Sciences Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L74100MH1993PLC075361 Incorporated 30 November 1993 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: CAMLINFINE · BSE: 532834 Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2026
₹1,723.31 Cr
▲ 3.41% YoY
EBITDA · FY 2026
₹135.67 Cr
▼ 39.04% YoY
Net profit · FY 2026
₹23.54 Cr
▲ 114.89% YoY
Authorised capital
₹21.5 Cr
Registered with MCA
Paid-up capital
₹19.21 Cr
Issued & subscribed
Open charges
₹663.75 Cr
Satisfied ₹1,187.59 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
612
Latest available

About Camlin Fine Sciences Limited

Data last updated: 05 January 2026

Camlin Fine Sciences Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 30 November 1993, the company has been in operation for over 33 years.

Registered with ROC Mumbai under CIN L74100MH1993PLC075361. Listed on BSE: 532834 and NSE: CAMLINFINE.

Capital: an authorised share capital of ₹21.5 Cr and a paid-up capital of ₹19.21 Cr. Formerly known as Camlicon Consultants Private Limited and Camlin Fine Chemicals Private Limited. It is led by directors including Amol Jashvant Shah and Santosh Laxman Parab.

Last AGM: 08 August 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,680.98 Cr, a growth of 14% compared to the previous year.

The company has a workforce of approximately 612 employees as per the latest available data. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand - Camlin Fine Sciences. As per MCA filings, the company has open charges of ₹663.75 Cr and satisfied charges of ₹1,187.59 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website camlinfs.com.

Company Details of Camlin Fine Sciences Limited
CIN L74100MH1993PLC075361
Registration Number 075361
Incorporation Date 30 November 1993
ROC Mumbai
Listing Status Listed (BSE: 532834, NSE: CAMLINFINE)
Company Status Active
Date of Last AGM 08 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Ashish Subhash Dandekar Managing Director Nirmal Vinod Momaya Managing Director Arjun Sudhakar Dukane Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    camlinfs.com
  • Social Media
  • Registered Address
    In G.S. Point Plot No. Viii C.S.T. Road Private Layout Scheme Kalina Santacruz, East, Mumbai, Maharashtra, India – 400098
  • Industry
    Chemicals and Materials, Specialty Chemicals
Company report
Camlin Fine Sciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Camlin Fine Sciences Limited report

Financials, compliance, directors, charges, ownership and filings for Camlin Fine Sciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Camlin Fine Sciences Limited

Camlin Fine Sciences Limited has undergone 3 name changes throughout its history. The company was previously known as Camlicon Consultants Private Limited, Camlin Fine Chemicals Private Limited, and Camlin Fine Chemicals Limited. The current legal name is Camlin Fine Sciences Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Camlin Fine Sciences Limited Current
Camlicon Consultants Private Limited Previous
Camlin Fine Chemicals Private Limited Previous
Camlin Fine Chemicals Limited Previous

CIN History of Camlin Fine Sciences Limited

Camlin Fine Sciences Limited has one previous CIN (Corporate Identification Number): U74100MH1993PLC075361. The current CIN is L74100MH1993PLC075361, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74100MH1993PLC075361 Current
U74100MH1993PLC075361 Previous

Associated Brands with Camlin Fine Sciences Limited

Camlin Fine Sciences Limited operates one associated brand: Camlin Fine Sciences. These brands represent Camlin Fine Sciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Camlin Fine Sciences
Manufacturer of fine chemicals catering to food industry camlinfs.com

Business Activity of Camlin Fine Sciences Limited

Camlin Fine Sciences Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Camlin Fine Sciences Limited

Camlin Fine Sciences Limited is audited by Kalyaniwalla and Mistry LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Kalyaniwalla and Mistry LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Camlin Fine Sciences Limited

Camlin Fine Sciences Limited is currently managed by 14 directors, with 30 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Amol Jashvant Shah
Also directs: Anglo Gulf Llp, Organic Biosystems Llp, Fine Aromatics And Herbal Extracts Private Limited and 5 more
Director 02 Aug 2019 6 Years 11 Months Current
Santosh Laxman Parab
Also directs: Bliss Gvs Pharma Limited
Cfo 10 Feb 2017 9 Years 4 Months Current
Josephconrad Agnelo Dsouza
Also directs: Prism Johnson Limited, Bharat Bijlee Limited, Chalet Hotels Limited and 5 more
Director 28 Sep 2020 5 Years 9 Months Current
Arjun Sudhakar Dukane
Also directs: Chemolutions Chemicals Limited, Naiknavare Chemicals Limited
Whole-Time Director 01 Jun 2018 8 Years 1 Months Current
Radhika Carlton Pereira
Also directs: Bajel Projects Limited, Jagson Pal Pharmaceuticals Limited., Tips Films Limited and 1 more
Director 12 Mar 2025 1 Years 3 Months Current
Anagha Dandekar Subhash
Also directs: Camart Finance Limited, Cafco Consultants Limited
Director 28 Aug 2017 8 Years 10 Months Current
Showing 6 of 14 current directors. View all directors

Financials of Camlin Fine Sciences Limited FY 2026 filings available

Camlin Fine Sciences Limited reported revenue of ₹1,723.31 Cr (up 3.41% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹1,723.31 Cr ▲ 3.41%
Profit · FY 2026
₹23.54 Cr ▲ 114.89%
EBITDA · FY 2026
₹135.67 Cr ▼ 39.04%
Revenue₹ Cr · Consolidated01,0002,000FY 2020: ₹1,049 Cr1,049FY 2020FY 2021: ₹1,187 Cr · +13.1% YoY1,187+13.1%FY 2021FY 2022: ₹1,412 Cr · +19% YoY1,412+19%FY 2022FY 2023: ₹1,682 Cr · +19.1% YoY1,682+19.1%FY 2023FY 2024: ₹1,613 Cr · -4.1% YoY1,613-4.1%FY 2024FY 2025: ₹1,667 Cr · +3.3% YoY1,667+3.3%FY 2025FY 2026: ₹1,723 Cr · +3.4% YoY1,723+3.4%FY 2026
Net Profit₹ Cr · Consolidated-200-1000100FY 2020: ₹30 Cr29.8FY 2020FY 2021: ₹65 Cr · +119.1% YoY65.4+119.1%FY 2021FY 2022: ₹60 Cr · -7.6% YoY60.4-7.6%FY 2022FY 2023: ₹40 Cr · -34.1% YoY39.8-34.1%FY 2023FY 2024: ₹105 Cr (loss) · -363.4% YoY-105FY 2024FY 2025: ₹158 Cr (loss) · -50.8% YoY-158FY 2025FY 2026: ₹24 Cr · +114.9% YoY23.5+114.9%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400600Q1'25: ₹396 Cr · -5.7% YoY396-5.7%Q1'25Q2'25: ₹423 Cr · +4.2% YoY423+4.2%Q2'25Q3'25: ₹433 Cr · +12.3% YoY433+12.3%Q3'25Q4'25: ₹437 Cr · +8.9% YoY437+8.9%Q4'25Q1'26: ₹424 Cr · +7% YoY424+7%Q1'26Q2'26: ₹460 Cr · +8.7% YoY460+8.7%Q2'26Q3'26: ₹457 Cr · +5.5% YoY457+5.5%Q3'26Q4'26: ₹425 Cr · -2.9% YoY425-2.9%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,723.31 Cr ₹1,666.53 Cr ₹1,613.06 Cr ₹1,681.56 Cr ₹1,412.09 Cr ₹1,187.1 Cr ₹1,049.15 Cr
Other Income ₹28.79 Cr ₹14.45 Cr ₹15.56 Cr ₹5.8 Cr ₹33.03 Cr ₹4.98 Cr ₹3.43 Cr
Total Income ₹1,752.1 Cr ₹1,680.98 Cr ₹1,628.62 Cr ₹1,687.36 Cr ₹1,445.12 Cr ₹1,192.09 Cr ₹1,052.58 Cr
Cost of Materials Consumed ₹823.27 Cr ₹786.26 Cr ₹746.61 Cr ₹855.57 Cr ₹727.6 Cr ₹488.03 Cr ₹499.71 Cr
Purchases of Stock-in-Trade ₹88.6 Cr ₹117.53 Cr ₹114.26 Cr ₹60.71 Cr ₹45.3 Cr ₹78.14 Cr ₹53.47 Cr
Changes in Inventories ₹10.57 Cr -₹54.54 Cr ₹52.75 Cr -₹103.05 Cr -₹13.41 Cr ₹17.32 Cr -₹19.39 Cr
Employee Benefit Expense ₹243.9 Cr ₹192.29 Cr ₹178.75 Cr ₹162.62 Cr ₹145.05 Cr ₹120.38 Cr ₹99.71 Cr
Finance Costs ₹72.94 Cr ₹99.88 Cr ₹60.3 Cr ₹58.5 Cr ₹35.77 Cr ₹37.53 Cr ₹43.13 Cr
Depreciation & Amortisation ₹70.92 Cr ₹63.84 Cr ₹78.61 Cr ₹62.51 Cr ₹55.96 Cr ₹44.29 Cr ₹32.8 Cr
Other Expenses ₹450.08 Cr ₹416.86 Cr ₹446.78 Cr ₹500.44 Cr ₹354.74 Cr ₹301.3 Cr ₹284.95 Cr
Total Expenses ₹1,760.29 Cr ₹1,622.14 Cr ₹1,678.06 Cr ₹1,597.31 Cr ₹1,351.01 Cr ₹1,086.99 Cr ₹994.38 Cr
Profit Before Exceptional Items & Tax -₹8.19 Cr ₹58.84 Cr -₹49.44 Cr ₹90.06 Cr ₹94.11 Cr ₹105.1 Cr ₹58.2 Cr
Exceptional Items -₹25.46 Cr -₹9.82 Cr -₹49.8 Cr -₹9.68 Cr ₹0 ₹0 ₹0
Profit Before Tax -₹33.65 Cr ₹49.03 Cr -₹99.24 Cr ₹80.38 Cr ₹94.11 Cr ₹105.1 Cr ₹58.2 Cr
Total Tax Expense -₹45.51 Lakh ₹6.65 Lakh ₹5.63 Cr ₹40.57 Cr ₹33.61 Cr ₹39.74 Cr ₹28.37 Cr
Net Profit ₹23.54 Cr -₹158.12 Cr -₹104.88 Cr ₹39.81 Cr ₹60.37 Cr ₹65.36 Cr ₹29.83 Cr
  attributable to Owners ₹27.63 Cr -₹139.05 Cr -₹92.75 Cr ₹52.11 Cr ₹60.69 Cr ₹50.96 Cr ₹30.32 Cr
  attributable to NCI -₹4.08 Cr -₹19.07 Cr -₹12.12 Cr -₹12.3 Cr -₹30.59 Lakh ₹14.39 Cr -₹48.78 Lakh
Other Comprehensive Income ₹3.44 Cr -₹12.23 Cr ₹17.96 Cr ₹20.23 Cr -₹7.77 Cr ₹113.5 Cr ₹1.3 Cr
Total Comprehensive Income ₹26.98 Cr -₹170.35 Cr -₹86.91 Cr ₹60.04 Cr ₹52.61 Cr ₹178.86 Cr ₹31.13 Cr
EBITDA (computed) ₹135.67 Cr ₹222.57 Cr ₹89.47 Cr ₹211.07 Cr ₹185.84 Cr ₹186.92 Cr ₹134.13 Cr
Basic EPS ₹-1.59 ₹2.89 ₹-5.58 ₹3.45 ₹4.65 ₹4.13 ₹2.50
Diluted EPS ₹-1.59 ₹2.86 ₹-5.50 ₹3.41 ₹4.56 ₹3.68 ₹2.50
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹2,323.9 Cr ₹2,023.79 Cr ₹1,951.72 Cr ₹2,060.1 Cr
Non-current Assets ₹1,087.41 Cr ₹840.39 Cr ₹951.06 Cr ₹972.28 Cr
Current Assets ₹1,234.33 Cr ₹1,183.39 Cr ₹998.6 Cr ₹1,085.75 Cr
Property, Plant & Equipment ₹625.09 Cr ₹592.56 Cr ₹756.76 Cr ₹793.6 Cr
Inventories ₹503.74 Cr ₹526.86 Cr ₹512.7 Cr ₹568.14 Cr
Trade Receivables ₹373.02 Cr ₹328.22 Cr ₹285.15 Cr ₹304.59 Cr
Cash & Equivalents ₹108.56 Cr ₹104.07 Cr ₹80.25 Cr ₹93.74 Cr
Equity (Net Worth) ₹1,000.81 Cr ₹874.78 Cr ₹856.95 Cr ₹824.08 Cr
Equity Share Capital ₹19.21 Cr ₹18.79 Cr ₹16.75 Cr ₹15.71 Cr
Borrowings (Non-current) ₹302.61 Cr ₹268.3 Cr ₹332.72 Cr ₹408.1 Cr
Borrowings (Current) ₹365.48 Cr ₹377.34 Cr ₹324.94 Cr ₹371.49 Cr
Total Debt (computed) ₹668.08 Cr ₹645.65 Cr ₹657.66 Cr ₹779.59 Cr
Current Liabilities ₹974.42 Cr ₹846.21 Cr ₹732.27 Cr ₹792.99 Cr
Total Liabilities ₹1,323.1 Cr ₹1,149.01 Cr ₹1,094.77 Cr ₹1,236.01 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹82.07 Cr ₹26.72 Cr ₹138.98 Cr ₹50.9 Cr ₹145.45 Cr
Investing Cash Flow -₹52.95 Cr -₹75.35 Cr -₹66.5 Cr -₹124.63 Cr -₹249.13 Cr
Financing Cash Flow -₹24.63 Cr ₹72.44 Cr -₹85.97 Cr ₹59.66 Cr ₹135.97 Cr
Capital Expenditure ₹57.57 Cr ₹42.45 Cr ₹60.58 Cr ₹144.31 Cr ₹213.79 Cr
Free Cash Flow (computed) ₹24.5 Cr -₹15.72 Cr ₹78.41 Cr -₹93.41 Cr -₹68.34 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹4.48 Cr ₹23.82 Cr -₹13.49 Cr -₹14.07 Cr ₹32.29 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹424.81 Cr ₹457.2 Cr ₹459.83 Cr ₹423.55 Cr ₹437.46 Cr ₹433.49 Cr ₹422.97 Cr ₹395.85 Cr ₹401.69 Cr ₹385.89 Cr ₹405.88 Cr ₹419.6 Cr
Other Income ₹23.91 Cr ₹2.94 Cr ₹4.59 Cr ₹8.56 Cr ₹9.59 Cr ₹1.34 Cr ₹12.1 Cr ₹1.87 Cr ₹5.76 Cr ₹1.66 Cr ₹1.76 Cr ₹6.37 Cr
Total Income ₹448.72 Cr ₹460.13 Cr ₹464.42 Cr ₹432.12 Cr ₹447.06 Cr ₹434.83 Cr ₹435.07 Cr ₹397.72 Cr ₹407.46 Cr ₹387.55 Cr ₹407.64 Cr ₹425.97 Cr
Cost of Materials Consumed ₹120.73 Cr ₹267.66 Cr ₹209.02 Cr ₹225.85 Cr ₹194.87 Cr ₹173.26 Cr ₹223.06 Cr ₹214.54 Cr ₹136.68 Cr ₹156.19 Cr ₹206.18 Cr ₹247.56 Cr
Purchases of Stock-in-Trade ₹18.16 Cr ₹13.73 Cr ₹31.92 Cr ₹17.41 Cr ₹2.36 Cr ₹45.4 Cr ₹53.93 Cr ₹15.84 Cr ₹43.31 Cr ₹39.02 Cr ₹12.26 Cr ₹19.67 Cr
Changes in Inventories ₹79.9 Cr -₹33.38 Cr ₹5.77 Cr -₹6.39 Cr ₹18.07 Cr -₹2.34 Cr -₹57.92 Cr -₹12.35 Cr ₹81.64 Cr ₹17.4 Cr ₹5.17 Cr -₹51.45 Cr
Employee Benefit Expense ₹65.93 Cr ₹63.76 Cr ₹60.29 Cr ₹59.57 Cr ₹50.13 Cr ₹51.96 Cr ₹52.28 Cr ₹51.18 Cr ₹46.17 Cr ₹45.49 Cr ₹43.24 Cr ₹43.85 Cr
Finance Costs ₹22.98 Cr ₹18.33 Cr ₹18.91 Cr ₹15.83 Cr ₹16.11 Cr ₹34.12 Cr ₹26.42 Cr ₹23.37 Cr ₹16.17 Cr ₹14.14 Cr ₹19.78 Cr ₹10.22 Cr
Depreciation & Amortisation ₹20.81 Cr ₹16.73 Cr ₹18.83 Cr ₹16.92 Cr ₹18.39 Cr ₹14.48 Cr ₹20.69 Cr ₹20.11 Cr ₹20.05 Cr ₹20.58 Cr ₹19.2 Cr ₹18.78 Cr
Other Expenses ₹118.91 Cr ₹123.39 Cr ₹119.41 Cr ₹108.07 Cr ₹112.63 Cr ₹116.43 Cr ₹108.38 Cr ₹108.5 Cr ₹107.15 Cr ₹104.47 Cr ₹113.9 Cr ₹121.26 Cr
Total Expenses ₹447.42 Cr ₹470.22 Cr ₹464.15 Cr ₹437.27 Cr ₹412.55 Cr ₹433.31 Cr ₹426.84 Cr ₹421.2 Cr ₹451.16 Cr ₹397.28 Cr ₹419.73 Cr ₹409.89 Cr
Profit Before Exceptional Items & Tax ₹1.3 Cr -₹10.09 Cr ₹26.53 Lakh -₹5.15 Cr ₹34.5 Cr ₹1.52 Cr ₹8.23 Cr -₹23.48 Cr -₹43.7 Cr -₹9.73 Cr -₹12.09 Cr ₹16.08 Cr
Exceptional Items -₹7.95 Cr -₹17.51 Cr ₹0 ₹0 -₹5.59 Cr ₹0 -₹151.04 Cr ₹0 -₹49.8 Cr ₹0 ₹0 ₹0
Profit Before Tax -₹6.65 Cr -₹27.6 Cr ₹26.53 Lakh -₹5.15 Cr ₹28.91 Cr ₹1.52 Cr -₹142.81 Cr -₹23.48 Cr -₹93.51 Cr -₹9.73 Cr -₹12.09 Cr ₹16.08 Cr
Total Tax Expense -₹6.24 Cr ₹4.52 Lakh ₹5.91 Cr -₹1 Lakh ₹7.95 Cr ₹7.14 Cr -₹26.2 Cr ₹11.17 Cr -₹11.72 Cr ₹4.55 Cr ₹8.74 Cr ₹4.06 Cr
Net Profit ₹86.28 Cr -₹37.1 Cr -₹14.95 Cr -₹10.68 Cr ₹11 Lakh -₹7.47 Cr -₹116.11 Cr -₹34.65 Cr -₹81.79 Cr -₹14.28 Cr -₹20.83 Cr ₹12.02 Cr
  attributable to Owners ₹88.2 Cr -₹36.23 Cr -₹14.38 Cr -₹9.96 Cr -₹72.4 Lakh -₹4.14 Cr -₹100.23 Cr -₹33.95 Cr -₹77.14 Cr -₹11.79 Cr -₹19.38 Cr ₹15.55 Cr
  attributable to NCI -₹1.92 Cr -₹87.3 Lakh -₹56.6 Lakh -₹72.04 Lakh ₹83.4 Lakh -₹3.34 Cr -₹15.88 Cr -₹69.61 Lakh -₹4.65 Cr -₹2.49 Cr -₹1.45 Cr -₹3.54 Cr
Other Comprehensive Income -₹11.89 Cr ₹4.38 Cr -₹97.82 Lakh ₹11.93 Cr ₹5.79 Cr -₹12.11 Cr ₹2.55 Lakh -₹5.95 Cr -₹92.3 Lakh ₹16.39 Cr -₹2.48 Cr ₹4.97 Cr
Total Comprehensive Income ₹74.39 Cr -₹32.72 Cr -₹15.93 Cr ₹1.25 Cr ₹5.9 Cr -₹19.58 Cr -₹116.08 Cr -₹40.6 Cr -₹82.71 Cr ₹2.11 Cr -₹23.31 Cr ₹16.99 Cr
EBITDA (computed) ₹45.1 Cr ₹24.97 Cr ₹38 Cr ₹27.59 Cr ₹69 Cr ₹50.13 Cr ₹55.34 Cr ₹20.01 Cr -₹7.49 Cr ₹24.99 Cr ₹26.89 Cr ₹45.08 Cr
Basic EPS ₹0.35 ₹-1.44 ₹-0.31 ₹-0.22 ₹1.17 ₹-0.24 ₹-5.98 ₹-2.03 ₹-4.64 ₹-0.71 ₹-1.17 ₹0.96
Diluted EPS ₹0.35 ₹-1.44 ₹-0.31 ₹-0.21 ₹1.16 ₹-0.24 ₹-5.93 ₹-2.01 ₹-4.58 ₹-0.70 ₹-1.16 ₹0.94
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹837.92 Cr ₹886.49 Cr ₹773.26 Cr ₹789.44 Cr ₹685.51 Cr ₹600.05 Cr ₹579.78 Cr
Other Income ₹34.95 Cr ₹20.62 Cr ₹18.88 Cr ₹28.83 Cr ₹18.7 Cr ₹5.47 Cr ₹24.06 Cr
Total Income ₹872.87 Cr ₹907.11 Cr ₹792.14 Cr ₹818.27 Cr ₹704.21 Cr ₹605.52 Cr ₹603.84 Cr
Cost of Materials Consumed ₹401.82 Cr ₹539.22 Cr ₹426.29 Cr ₹402.75 Cr ₹382.17 Cr ₹384.18 Cr ₹377.42 Cr
Purchases of Stock-in-Trade ₹3.69 Cr ₹16.95 Cr ₹8.46 Cr ₹5.54 Cr ₹7.62 Cr ₹16.04 Cr ₹13.48 Cr
Changes in Inventories ₹40.4 Cr -₹74.91 Cr ₹8.92 Cr -₹42.61 Cr ₹4.72 Cr -₹21.83 Cr -₹2.06 Cr
Employee Benefit Expense ₹75.98 Cr ₹72.48 Cr ₹65.95 Cr ₹59.71 Cr ₹52.89 Cr ₹38.7 Cr ₹28.01 Cr
Finance Costs ₹66.99 Cr ₹66.12 Cr ₹54.33 Cr ₹56.94 Cr ₹33.43 Cr ₹32.54 Cr ₹28.07 Cr
Depreciation & Amortisation ₹53.68 Cr ₹52.53 Cr ₹49.39 Cr ₹32.82 Cr ₹26.68 Cr ₹19.28 Cr ₹11.28 Cr
Other Expenses ₹268.13 Cr ₹262.15 Cr ₹236.52 Cr ₹236.47 Cr ₹160.64 Cr ₹121.08 Cr ₹103.22 Cr
Total Expenses ₹910.69 Cr ₹934.54 Cr ₹849.85 Cr ₹751.64 Cr ₹668.14 Cr ₹590 Cr ₹559.42 Cr
Profit Before Exceptional Items & Tax -₹37.82 Cr -₹27.43 Cr -₹57.7 Cr ₹66.63 Cr ₹36.08 Cr ₹15.52 Cr ₹44.43 Cr
Exceptional Items -₹16.27 Cr -₹96 Cr -₹1.93 Cr ₹0 ₹0 -₹50.32 Lakh -₹3.14 Cr
Profit Before Tax -₹54.09 Cr -₹123.43 Cr -₹59.63 Cr ₹66.63 Cr ₹36.08 Cr ₹15.02 Cr ₹41.29 Cr
Total Tax Expense -₹21.13 Cr -₹47.12 Cr -₹8.24 Cr ₹19.07 Cr ₹10.21 Cr ₹6.74 Cr ₹10.56 Cr
Net Profit -₹32.97 Cr -₹76.31 Cr -₹51.39 Cr ₹47.55 Cr ₹25.87 Cr ₹8.28 Cr ₹30.72 Cr
Other Comprehensive Income -₹4.7 Cr -₹54.04 Lakh -₹4.46 Lakh -₹65.96 Lakh -₹15.16 Lakh -₹37.97 Lakh -₹29.14 Lakh
Total Comprehensive Income -₹37.66 Cr -₹76.85 Cr -₹51.43 Cr ₹46.9 Cr ₹25.72 Cr ₹7.9 Cr ₹30.43 Cr
EBITDA (computed) ₹82.84 Cr ₹91.22 Cr ₹46.01 Cr ₹156.39 Cr ₹96.19 Cr ₹67.34 Cr ₹83.78 Cr
Basic EPS ₹-1.74 ₹-4.41 ₹-3.09 ₹3.18 ₹1.98 ₹0.67 ₹2.53
Diluted EPS ₹-1.74 ₹-4.36 ₹-3.05 ₹3.14 ₹1.94 ₹0.60 ₹2.53
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,771.88 Cr ₹1,628.68 Cr ₹1,571.99 Cr ₹1,345.94 Cr
Non-current Assets ₹850.45 Cr ₹699.3 Cr ₹711.49 Cr ₹625.39 Cr
Current Assets ₹919.27 Cr ₹929.38 Cr ₹858.43 Cr ₹718.47 Cr
Property, Plant & Equipment ₹513.98 Cr ₹520.31 Cr ₹559.94 Cr ₹282.44 Cr
Inventories ₹243.51 Cr ₹263.16 Cr ₹254.91 Cr ₹142.5 Cr
Trade Receivables ₹474.1 Cr ₹414.48 Cr ₹491.81 Cr ₹440.65 Cr
Cash & Equivalents ₹36.22 Cr ₹36.07 Cr ₹67.7 Lakh ₹22.17 Cr
Equity (Net Worth) ₹928.83 Cr ₹862.27 Cr ₹715.71 Cr ₹592.34 Cr
Equity Share Capital ₹19.21 Cr ₹18.79 Cr ₹16.75 Cr ₹15.7 Cr
Borrowings (Non-current) ₹210.39 Cr ₹171.86 Cr ₹222.31 Cr ₹258.27 Cr
Borrowings (Current) ₹261.4 Cr ₹269.96 Cr ₹269.32 Cr ₹190.05 Cr
Total Debt (computed) ₹471.78 Cr ₹441.82 Cr ₹491.62 Cr ₹448.33 Cr
Current Liabilities ₹621.36 Cr ₹579.52 Cr ₹607.46 Cr ₹471.73 Cr
Total Liabilities ₹843.06 Cr ₹766.41 Cr ₹856.28 Cr ₹753.59 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹43.96 Cr ₹21.86 Cr ₹82.1 Cr ₹18.52 Cr ₹46.8 Cr
Investing Cash Flow -₹30.4 Cr -₹87.66 Cr -₹51.72 Cr -₹114.73 Cr -₹172.33 Cr
Financing Cash Flow -₹13.41 Cr ₹101.19 Cr -₹34.05 Cr ₹78.39 Cr ₹128.92 Cr
Capital Expenditure ₹27.58 Cr ₹22.63 Cr ₹41 Cr ₹131.19 Cr ₹189.49 Cr
Free Cash Flow (computed) ₹16.38 Cr -₹77.09 Lakh ₹41.11 Cr -₹112.66 Cr -₹142.7 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹15.3 Lakh ₹35.39 Cr -₹3.67 Cr -₹17.82 Cr ₹3.39 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹183.52 Cr ₹218.92 Cr ₹244.04 Cr ₹191.44 Cr ₹272.6 Cr ₹205.07 Cr ₹226.91 Cr ₹181.91 Cr ₹220.33 Cr ₹185.61 Cr ₹206.21 Cr ₹161.11 Cr
Other Income ₹15.3 Cr ₹5.77 Cr ₹10.19 Cr ₹3.69 Cr ₹10.21 Cr ₹6.82 Cr ₹3.08 Cr ₹1.78 Cr ₹5.55 Cr ₹2.13 Cr ₹5.63 Cr ₹6.01 Cr
Total Income ₹198.82 Cr ₹224.69 Cr ₹254.24 Cr ₹195.13 Cr ₹282.81 Cr ₹211.89 Cr ₹229.99 Cr ₹183.69 Cr ₹225.88 Cr ₹187.73 Cr ₹211.85 Cr ₹167.12 Cr
Cost of Materials Consumed ₹77.68 Cr ₹110.68 Cr ₹114.4 Cr ₹99.06 Cr ₹150.03 Cr ₹106.45 Cr ₹151.05 Cr ₹131.7 Cr ₹108.32 Cr ₹103.72 Cr ₹113.49 Cr ₹100.76 Cr
Purchases of Stock-in-Trade ₹2.04 Cr ₹80.58 Lakh ₹37.11 Lakh ₹47.1 Lakh ₹58.24 Lakh ₹48.25 Lakh ₹13.63 Cr ₹2.26 Cr ₹3.88 Cr ₹1.02 Cr ₹2.65 Cr ₹90.77 Lakh
Changes in Inventories ₹16.8 Cr ₹1.29 Cr ₹19.37 Cr ₹2.95 Cr -₹3.26 Cr -₹5.63 Cr -₹34.06 Cr -₹31.96 Cr ₹52.8 Cr ₹2.88 Cr -₹8.31 Cr -₹38.45 Cr
Employee Benefit Expense ₹18.07 Cr ₹19.93 Cr ₹19.36 Cr ₹18.62 Cr ₹18.89 Cr ₹17.18 Cr ₹19.6 Cr ₹16.81 Cr ₹16.54 Cr ₹16.23 Cr ₹17.7 Cr ₹15.48 Cr
Finance Costs ₹22.05 Cr ₹14.86 Cr ₹18.73 Cr ₹11.34 Cr ₹17.44 Cr ₹17.15 Cr ₹17.92 Cr ₹13.62 Cr ₹13.88 Cr ₹13.3 Cr ₹15.1 Cr ₹12.05 Cr
Depreciation & Amortisation ₹13.28 Cr ₹13.51 Cr ₹13.47 Cr ₹13.4 Cr ₹13.13 Cr ₹13.26 Cr ₹13.44 Cr ₹12.69 Cr ₹12.78 Cr ₹12.4 Cr ₹12.41 Cr ₹11.8 Cr
Other Expenses ₹62.91 Cr ₹67.22 Cr ₹72.35 Cr ₹65.65 Cr ₹74.36 Cr ₹70.2 Cr ₹62.69 Cr ₹56.17 Cr ₹64.42 Cr ₹55.88 Cr ₹59.34 Cr ₹57.32 Cr
Total Expenses ₹212.84 Cr ₹228.3 Cr ₹258.05 Cr ₹211.5 Cr ₹271.18 Cr ₹219.08 Cr ₹244.26 Cr ₹201.29 Cr ₹272.64 Cr ₹205.42 Cr ₹212.37 Cr ₹159.86 Cr
Profit Before Exceptional Items & Tax -₹14.02 Cr -₹3.61 Cr -₹3.81 Cr -₹16.38 Cr ₹11.63 Cr -₹7.19 Cr -₹14.27 Cr -₹17.6 Cr -₹46.75 Cr -₹17.69 Cr -₹52.34 Lakh ₹7.26 Cr
Exceptional Items -₹2.61 Cr -₹13.66 Cr ₹0 ₹0 ₹26.45 Lakh ₹0 -₹96.27 Cr ₹0 -₹1.93 Cr ₹0 ₹0 ₹0
Profit Before Tax -₹16.64 Cr -₹17.27 Cr -₹3.81 Cr -₹16.38 Cr ₹11.9 Cr -₹7.19 Cr -₹110.54 Cr -₹17.6 Cr -₹48.68 Cr -₹17.69 Cr -₹52.34 Lakh ₹7.26 Cr
Total Tax Expense -₹10.99 Cr -₹4.27 Cr -₹17.11 Lakh -₹5.7 Cr -₹3.72 Cr -₹1.57 Cr -₹37.91 Cr -₹3.92 Cr -₹4.61 Cr -₹6.05 Cr ₹93.22 Lakh ₹1.48 Cr
Net Profit -₹5.65 Cr -₹13 Cr -₹3.64 Cr -₹10.68 Cr ₹15.62 Cr -₹5.63 Cr -₹72.62 Cr -₹13.68 Cr -₹44.07 Cr -₹11.64 Cr -₹1.46 Cr ₹5.78 Cr
Other Comprehensive Income -₹99.22 Lakh ₹32.47 Lakh -₹4.25 Cr ₹22.47 Lakh ₹1.94 Cr -₹2.32 Cr -₹71.53 Lakh ₹55.3 Lakh -₹22.49 Lakh -₹8.76 Lakh -₹1.04 Cr ₹1.31 Cr
Total Comprehensive Income -₹6.64 Cr -₹12.67 Cr -₹7.89 Cr -₹10.46 Cr ₹17.56 Cr -₹7.95 Cr -₹73.34 Cr -₹13.13 Cr -₹44.3 Cr -₹11.73 Cr -₹2.5 Cr ₹7.09 Cr
EBITDA (computed) ₹21.31 Cr ₹24.77 Cr ₹28.39 Cr ₹8.37 Cr ₹42.21 Cr ₹23.21 Cr ₹17.08 Cr ₹8.71 Cr -₹20.09 Cr ₹8.01 Cr ₹26.99 Cr ₹31.11 Cr
Basic EPS ₹-0.29 ₹-0.69 ₹-0.19 ₹-0.57 ₹0.86 ₹-0.33 ₹-4.34 ₹-0.82 ₹-2.65 ₹-0.70 ₹-0.09 ₹0.36
Diluted EPS ₹-0.29 ₹-0.69 ₹-0.19 ₹-0.56 ₹0.85 ₹-0.33 ₹-4.29 ₹-0.81 ₹-2.61 ₹-0.69 ₹-0.09 ₹0.35
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Camlin Fine Sciences Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Camlin Fine Sciences Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 48.03%, foreign institutional investors hold 0.94%, domestic institutional investors hold 7.70%, retail and other public shareholders hold 43.32% of Camlin Fine Sciences Limited. The company had 52,232 shareholders on record.

Promoters: 48.03%DII (Domestic Institutional): 7.70%FII (Foreign Institutional): 0.94%Retail & Others: 43.32%
Mar 2026
QUARTER
48.03% Promoters
7.70% DII (Domestic Institutional)
0.94% FII (Foreign Institutional)
43.32% Retail & Others
Promoter holding - history
Now 48.03% · Mar 2026High 49.10% · Jan 2025Low 16.52% · May 2023
15%24%33%42%51%Dec 2015Jun 2018Dec 2020May 2023Sep 2025Dec 2015: 39.94%Mar 2016: 39.84%Jun 2016: 39.84%Sep 2016: 41.14%Dec 2016: 41.14%Mar 2017: 40.95%Jun 2017: 40.96%Sep 2017: 40.93%Nov 2017: 35.08%Dec 2017: 35.05%Mar 2018: 22.37%Jun 2018: 22.39%Sep 2018: 22.49%Dec 2018: 22.66%Mar 2019: 22.66%Jun 2019: 22.66%Sep 2019: 22.70%Dec 2019: 22.85%Mar 2020: 22.85%Jun 2020: 22.85%Sep 2020: 22.84%Nov 2020: 21.74%Dec 2020: 21.74%Mar 2021: 21.73%Jun 2021: 21.71%Sep 2021: 21.71%Dec 2021: 21.71%Feb 2022: 17.65%Mar 2022: 17.65%Jun 2022: 17.64%Sep 2022: 17.64%Dec 2022: 17.64%Mar 2023: 17.64%May 2023: 16.52%Jun 2023: 16.52%Sep 2023: 48.03%Dec 2023: 48.03%Mar 2024: 48.03%Jun 2024: 48.02%Sep 2024: 48.02%Dec 2024: 48.02%Jan 2025: 49.10%Mar 2025: 49.10%Jun 2025: 49.10%Sep 2025: 49.08%Nov 2025: 48.03%Dec 2025: 48.03%Mar 2026: 48.03%49.10%16.52%48.03%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Nov 2025Sep 2025Jun 2025Mar 2025
Promoters48.03%48.03%48.03%49.08%49.10%49.10%
Public51.97%51.97%51.97%50.92%50.90%50.90%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters48.03%49.10%48.03%17.64%17.65%21.73%22.85%22.66%22.37%40.95%39.84%
Public51.97%50.90%51.97%82.36%82.35%78.27%77.15%77.34%77.63%59.05%60.16%
Promoter change (YoY, %pts)-1.07+1.07+30.39-0.01-4.08-1.12+0.19+0.29-18.58+1.11-

Board & Governance of Camlin Fine Sciences Limited

As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Camlin Fine Sciences Limited has 12 directors - 6 independent and 3 executive. The board is chaired by Ashish Subhash Dandekar.

DirectorPositionOn board sinceListed boards
Ashish Subhash Dandekar Executive Director · MD · Chairperson 2007-01-11 1
Anagha Subhash Dandekar Non-Executive - Non Independent Director 2018-08-13 1
Nirmal Vinod Momaya Executive Director · MD 2014-08-04 2
Arjun Sudhakar Dukane Executive Director 2018-06-01 1
Amol Jashvant Shah Non-Executive - Independent Director 2019-08-02 1
Harsha Raghavan Non-Executive - Non Independent Director 2020-08-10 4
Josephconrad Agnelo Dsouza Non-Executive - Independent Director 2020-09-29 5
M G Palekar Non-Executive - Independent Director 2020-12-24 2
Pradip Manilal Kanakia Non-Executive - Independent Director 2021-10-18 6
Abeezar E Faizullabhoy Non-Executive - Independent Director 2025-02-04 1
Jens Van Nieuwenborgh Non-Executive - Non Independent Director 2025-03-12 2
Radhika Madhukar Dudhat Non-Executive - Independent Director 2025-03-12 4
Board Committees
CommitteeMembers
Audit Committee Pradip Manilal Kanakia (Chairperson), Amol Jashvant Shah, Harsha Raghavan, M G Palekar, Josephconrad Agnelo Dsouza, Abeezar E Faizullabhoy, Jens Van Nieuwenborgh, Radhika Madhukar Dudhat
Nomination and remuneration committee Pradip Manilal Kanakia, Amol Jashvant Shah, Harsha Raghavan, M G Palekar, Josephconrad Agnelo Dsouza (Chairperson), Abeezar E Faizullabhoy, Jens Van Nieuwenborgh, Radhika Madhukar Dudhat
Stakeholders Relationship Committee M G Palekar (Chairperson), Ashish Subhash Dandekar, Nirmal Vinod Momaya, Radhika Madhukar Dudhat
Risk Management Committee Amol Jashvant Shah (Chairperson), Nirmal Vinod Momaya, Arjun Sudhakar Dukane, M G Palekar
Corporate Social Responsibility Committee M G Palekar (Chairperson), Nirmal Vinod Momaya, Ashish Subhash Dandekar

Group Structure of Camlin Fine Sciences Limited

Camlin Fine Sciences Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Camlin Fine Sciences Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Chemolutions Chemicals Ltd. U24100MH2008PLC180376 -
Algalr Nutrapharms Private Limited U74900TN2014PTC096649 -

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Camlin Fine Sciences Limited

Open charges
₹663.75 Cr
Satisfied charges
₹1,187.59 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹456.15 Cr
Idbi Trusteeship Services Limited₹110.00 Cr
Others₹96.82 Cr
Hdfc Bank Limited₹0.78 Cr
Latest charge details
DateLenderAmountStatus
14 Nov 2025 Others ₹17 Lakh Open
27 Jun 2023 Hdfc Bank Limited ₹44 Lakh Open
01 Sep 2022 Others ₹1.65 Cr Open
21 Jul 2022 Others ₹95 Cr Open
20 May 2022 Hdfc Bank Limited ₹34.3 Lakh Open

Total charge records: 37 View all charges

Employees and EPFO Compliance at Camlin Fine Sciences Limited

Camlin Fine Sciences Limited has a workforce of 612 employees as of Apr 09, 2024.

Employee count
612
Active EPFO establishments
2
Employee growth
6.62%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Camlin Fine Sciences Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Camlin Fine Sciences Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Camlin Fine Sciences Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Camlin Fine Sciences Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Camlin Fine Sciences Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Camlin Fine Sciences Limited

MSME Payment Delays by Camlin Fine Sciences Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Camlin Fine Sciences Limited

Subsidiaries & Group Companies of Camlin Fine Sciences Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Camlin Fine Sciences Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Camlin Fine Sciences Limited

MCA Filings & Documents of Camlin Fine Sciences Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Camlin Fine Sciences Limited

Charges
16 Dec 2025
A charge with Others of Rs. 0.17 Cr registered on 14 Nov 2025 with Charge ID 101196871 was modified on 16 Dec 2025.
Charges
14 Nov 2025
A charge with Others amounted to Rs. 0.17 Cr with Charge ID 101196871 was registered on 14 Nov 2025.
Activity
08 Aug 2025
Camlin Fine Sciences Limited last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Camlin Fine Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
12 Mar 2025
Radhika Carlton Pereira was appointed as a Director on 12 Mar 2025 & has been associated with this company since 1 year 3 months.
Directors
12 Mar 2025
Jens Van Nieuwenborgh was appointed as a Director on 12 Mar 2025 & has been associated with this company since 1 year 3 months.

Recent News on Camlin Fine Sciences Limited

Frequently Asked Questions about Camlin Fine Sciences Limited

Camlin Fine Sciences Limited is an active public limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 30 November 1993 (33+ years old) and is registered under CIN L74100MH1993PLC075361. Listed on BSE: 532834 and NSE: CAMLINFINE. The company has 612 employees.

Camlin Fine Sciences Limited reported revenue of ₹1,680.98 Cr for FY 2025 (up 14.00% YoY).

The current directors of Camlin Fine Sciences Limited are:

The primary industry of Camlin Fine Sciences Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.

Yes. Camlin Fine Sciences Limited is listed on both BSE (code: 532834) and NSE (symbol: CAMLINFINE).

Camlin Fine Sciences Limited can be reached at the registered office: In G.S. Point Plot No. Viii C.S.T. Road Private Layout Scheme Kalina Santacruz, East, Mumbai, Maharashtra, India – 400098, or through the website camlinfs.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available